ORPHA: 2162, 220386, 280195, 280200, 93924, 93925, 93926; DO: 0110872;
| Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
|---|---|---|---|---|---|---|
| 2p21 | Holoprosencephaly 2 | 157170 | Autosomal dominant | 3 | SIX3 | 603714 |
A number sign (#) is used with this entry because of evidence that holoprosencephaly-2 (HPE2) is caused by heterozygous mutation in the homeobox-containing SIX3 gene (603714) on chromosome 2p21.
For phenotypic information and a general discussion of genetic heterogeneity in holoprosencephaly, see HPE1 (236100).
Martin et al. (1977) described a kindred with 7 persons affected with a syndrome manifested by cleft lip and anterior cleft palate, hypotelorism, microcephaly, mental retardation, scoliosis, and chronic constipation. The disorder bore similarities to familial holoprosencephaly. Three of 4 affected males survived past 20 years of age. All 3 affected females died early in infancy. Although no affected male begot an affected son, 2 presumed carrier males had an affected son.
Jaramillo et al. (1988) described a family in which several persons had variable combinations of craniofacial defects. The most severely affected relatives had holoprosencephaly, whereas others had only mild facial dysmorphism and decreased bitemporal diameters. One member of the family had a single central maxillary incisor. Male-to-male transmission occurred.
Hennekam et al. (1991) described a family in which 1 sib had holoprosencephaly and microcephaly, a second sib had microcephaly alone, and the mother had microcephaly with single central maxillary incisor, submucous cleft palate, absence of the nasal septal cartilage, and hypotelorism.
Solomon et al. (2009) reported a large kindred in which at least 15 individuals spanning 5 generations had a variable severity of holoprosencephaly. The proband was ascertained at birth because of alobar HPE, macrocephaly, severe hypotelorism, short nose with upturned nares, hypoplastic philtrum, and low-set ears. In a family review, 2 deceased individuals had full HPE as observed in the proposita, 5 had died in early infancy from unknown causes, and at least 9 had a subtle facial microform with short angular nose with hypotelorism or narrow nasal bridge. Genetic analysis identified a heterozygous mutation (W113C; 603714.0007) in the SIX3 gene in 6 affected individuals. Solomon et al. (2009) commented that the studies of this family spanned 15 years, and that the analysis was complicated by reduced penetrance, variable expressivity, and phenocopies.
By detailed ophthalmologic examination of 3 patients with genetically confirmed HPE2, Pineda-Alvarez et al. (2011) found several subtle abnormalities, including refractory errors, small corneal diameter, astigmatism, cataracts, fine nystagmus, strabismus, and dysplastic optic nerve. The patients were part of a larger cohort of 10 patients with genetically confirmed HPE. All had at least 2 ophthalmologic anomalies, including refractive errors, microcornea, microphthalmia, blepharoptosis, exotropia, and coloboma. The findings contributed to the understanding of the phenotypic variability of the HPE spectrum and showed that subtle intraocular abnormalities can occur in HPE.
Cantu et al. (1978) described holoprosencephaly in 2 successive generations and suggested autosomal dominant inheritance. Some heterozygotes had mild abnormalities of midface development.
Benke and Cohen (1983) described a kindred ascertained through a holoprosencephalic child and containing 6 other affected members in 3 generations. Dominant inheritance with reduced penetrance was suggested.
Odent et al. (1998) reviewed 258 holoprosencephaly records involving at least 1 affected child and found 97 cases in 79 families with nonsyndromic, nonchromosomal holoprosencephaly. A high degree of familial aggregation was found in 29% of families. By segregation analysis, Odent et al. (1998) concluded that autosomal dominant inheritance with incomplete penetrance (82% for major and 88% for major and minor) was the most likely mode of inheritance. Sporadic cases accounted for 68%, and the recurrence risk after an isolated case was predicted to be 13 to 14%.
On the basis of 3 patients with holoprosencephaly and various interstitial deletions of chromosome 2q, Munke et al. (1989) hypothesized that the gene involved in early embryonic brain development is located in band 2p21, the smallest of the 3 overlapping deletions. Grundy et al. (1989) reported a case of synophthalmic cyclopia and alobar holoprosencephaly associated with an interstitial deletion del(2)(p21p23). Cytogenetic abnormalities observed in several reported cases point to the location of a causative gene on 2p, specifically 2p21 (Hecht et al., 1991).
Schell et al. (1996) reported the molecular genetic characterization of 9 HPE patients with cytogenetic deletions or translocations involving 2p21. They determined the parental origin of the deleted chromosomes and defined the HPE2 critical region between D2S119 and D2S88/D2S391. As a first step toward cloning the HPE2 gene which is clearly crucial for normal brain development, they constructed a YAC contig that spans the smallest region of deletion overlap. Several of the YACs spanned 3 different 2p21 breakpoints in HPE patients. These YACs narrowed the HPE2 critical region to less than 1 Mb.
Wallis et al. (1999) demonstrated mutations in the SIX3 gene (603714.0001-603714.0003) in patients with holoprosencephaly.
In 6 Brazilian patients with HPE2, Ribeiro et al. (2006) identified 5 missense mutations and 2 frameshift mutations in the SIX3 gene. Comparison of patients with missense versus frameshift mutations showed essentially no difference. Experience with these patients suggested that SIX3 mutations result in a more severe phenotype than other gene mutations for holoprosencephaly. One patient had a double heterozygosity for SIX3 mutation (603714.0005 and 603714.0006). Three mutations were paternally transmitted, 2 were maternal, and 1 was a de novo event. The 5 parental mutation carriers appeared normal.
Among 94 fetuses with HPE and a normal karyotype, Bendavid et al. (2006) used quantitative multiplex PCR of short fluorescent fragments (QMPSF) to screen for microdeletions in the 4 major HPE genes, SHH (600725), SIX3, ZIC2 (603073), and TGIF (602630). Microdeletions were identified in 8 (8.5%) fetuses: 2 in SHH, 2 in SIX3, 3 in ZIC2, and 1 in TGIF. Further analysis showed that the entire gene was missing in each case. Point mutations in 1 of the 4 genes were identified in 13 of the fetuses. Combining the instances of point mutations and microdeletions for the 94 cases yielded the following percentages: SHH (6.3%), ZIC2 (8.5%), SIX3 (5.3%), and TGIF (2%). Bendavid et al. (2006) reported the use of 2 complementary assays for HPE-associated submicroscopic deletions: a multicolor fluorescence in situ hybridization (FISH) assay using probes for the 4 major HPE genes and 2 candidate genes (DISP1, 607502 and FOXA2, 600288) followed by quantitative PCR to selected samples. Microdeletions for SHH, ZIC2, SIX3, or TGIF were found in 16 of 339 severe HPE cases (i.e., with CNF findings; 4.7%). In contrast, no deletions were found in 85 patients at the mildest end of the HPE spectrum. Based on their data, Bendavid et al. (2006) suggested that microdeletion testing should be considered as part of an evaluation of holoprosencephaly, especially in severe HPE cases.
Among 34 patients with holoprosencephaly, Dubourg et al. (2004) observed that mutation in the SIX3 gene was associated with atelencephaly.
Lacbawan et al. (2009) identified SIX3 mutations in 4.7% of 800 probands and relatives with HPE. In total, 138 cases of HPE were identified, 59 of whom had not previously been reported. Mutations in SIX3 resulted in more severe HPE than in other cases of nonchromosomal, nonsyndromic HPE. An overrepresentation of severe HPE was found in patients whose mutations conferred greater loss of protein function, as measured by an in vitro assay. The gender ratio in this combined set of patients was 1.5:1 (F:M), and maternal inheritance was almost twice as common as paternal. About 14% of SIX3 mutations in probands occurred de novo. There was a wide intrafamilial clinical range of features, and penetrance was estimated to be at least 62% from diagnosis on clinical grounds alone. The data suggested that SIX3 mutations result in relatively severe HPE, but also indicated that variability may be due to a multi-hit mechanism.
Mercier et al. (2011) reported the clinical and molecular features of a large European series of 645 HPE probands (51% fetuses) and 699 relatives in order to examine genotype/phenotype correlations. The facial features were assigned to 4 categories: categories 1 and 2 had severe facial defects, whereas microforms were listed as 3 and 4. SIX3 mutations were found in 5.1% of probands, and most (57%) had severe HPE, including atelencephaly/aprosencephaly, as well as severe facial and ophthalmologic defects. About 24% had extracraniofacial defects, mostly visceral, skeletal, and of the extremities. The sex ratio favored females, suggesting that SIX3 mutations may be embryonically lethal in males. SIX3 mutations were highly heritable (88%), but only 3 of 17 parents had a microform. Statistical analysis showed a positive correlation between the severity of the brain malformation and facial features for SIX3 mutations, and those with SIX3 mutations had a more severe HPE type compared to those with other mutations. Based on these results, Mercier et al. (2011) proposed an algorithm for molecular analysis in HPE.
In a targeted screening study of 4 genes in 186 Dutch patients with holoprosencephaly, Paulussen et al. (2010) found that 21 (24%) had heterozygous mutations in 1 of 3 of the genes. Three (3.5%) had mutations in the SHH gene (600725), 9 (10.5%) had mutations in the ZIC2 gene (603073), and 9 (10.5%) had mutations in the SIX3 gene. None had mutations in the TGIF gene (602630). Two deletions were detected, 1 encompassing the ZIC2 gene and another encompassing the SIX3 gene. About half of the mutations were de novo; 1 was germline mosaic. There was marked clinical variability, but those with ZIC2 mutations tended to have less severe facial malformations. Five of 7 parental carriers were asymptomatic, and 2 had minor HPE signs.
Bendavid, C., Dubourg, C., Gicquel, I., Pasquier, L., Saugier-Veber, P., Durou, M.-R., Jaillard, S., Frebourg, T., Haddad, B. R., Henry, C., Odent, S., David, V. Molecular evaluation of foetuses with holoprosencephaly shows high incidence of microdeletions in the HPE genes. Hum. Genet. 119: 1-8, 2006. [PubMed: 16323008] [Full Text: https://doi.org/10.1007/s00439-005-0097-6]
Bendavid, C., Haddad, B. R., Griffin, A., Huizing, M., Dubourg, C., Gicquel, I., Cavalli, L. R., Pasquier, L., Shanske, A. L., Long, R., Ouspenskaia, M., Odent, S., Lacbawan, F., David, V., Muenke, M. Multicolour FISH and quantitative PCR can detect submicroscopic deletions in holoprosencephaly patients with a normal karyotype. J. Med. Genet. 43: 496-500, 2006. [PubMed: 16199538] [Full Text: https://doi.org/10.1136/jmg.2005.037176]
Benke, P. J., Cohen, M. M., Jr. Recurrence of holoprosencephaly in families with a positive history. Clin. Genet. 24: 324-328, 1983. [PubMed: 6652942]
Cantu, J.-M., Fragoso, R., Garcia-Cruz, D., Sanchez-Corona, J. Dominant inheritance of holoprosencephaly. Birth Defects Orig. Art. Ser. 14(6B): 215-220, 1978. [PubMed: 728563]
Dubourg, C., Lazaro, L., Pasquier, L., Bendavid, C., Blayau, M., Le Duff, F., Durou, M.-R., Odent, S., David, V. Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: mutation review and genotype-phenotype correlations. Hum. Mutat. 24: 43-51, 2004. [PubMed: 15221788] [Full Text: https://doi.org/10.1002/humu.20056]
Grundy, H. O., Niemeyer, P., Rupani, M. K., Ward, V. F., Wassman, E. R. Prenatal detection of cyclopia associated with interstitial deletion of 2p. Am. J. Med. Genet. 34: 268-270, 1989. [PubMed: 2817010] [Full Text: https://doi.org/10.1002/ajmg.1320340231]
Hecht, B. K.-M., Hecht, F., Munke, M. Forebrain cleavage gene causing holoprosencephaly: deletion mapping to chromosome band 2p21. (Letter) Am. J. Med. Genet. 40: 130, 1991. [PubMed: 1887845] [Full Text: https://doi.org/10.1002/ajmg.1320400131]
Hennekam, R. C. M., Van Noort, G., de la Fuente, F. A., Norbruis, O. F. Agenesis of the nasal septal cartilage: another sign in autosomal dominant holoprosencephaly. (Letter) Am. J. Med. Genet. 39: 121-122, 1991. [PubMed: 1844347] [Full Text: https://doi.org/10.1002/ajmg.1320390127]
Jaramillo, C., Brandt, S. K., Jorgenson, R. J. Autosomal dominant inheritance of the DeMyer sequence. J. Craniofac. Genet. Dev. Biol. 8: 199-204, 1988. [PubMed: 3209682]
Lacbawan, F., Solomon, B. D., Roessler, E., El-Jaick, K., Domene, S., Velez, J. I., Zhou, N., Hadley, D., Balog, J. Z., Long, R., Fryer, A., Smith, W., and 34 others. Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function. J. Med. Genet. 46: 389-398, 2009. [PubMed: 19346217] [Full Text: https://doi.org/10.1136/jmg.2008.063818]
Martin, A. O., Perrin, J. C. S., Muir, W. A., Ruch, E., Schafer, I. A. An autosomal dominant midline cleft syndrome resembling familial holoprosencephaly. Clin. Genet. 12: 65-72, 1977. [PubMed: 891015] [Full Text: https://doi.org/10.1111/j.1399-0004.1977.tb00903.x]
Mercier, S., Dubourg, C., Garcelon, N., Campillo-Gimenez, B., Gicquel, I., Belleguic, M., Ratie, L., Pasquier, L., Loget, P., Bendavid, C., Jaillard, S., Rochard, L., Quelin, C., Dupe, V., David, V., Odent, S. New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases. J. Med. Genet. 48: 752-760, 2011. [PubMed: 21940735] [Full Text: https://doi.org/10.1136/jmedgenet-2011-100339]
Munke, M., Sosnoski, D. M., Wilson, W. G., Wassman, E. R., Davidson, J. N., Patterson, D., Nussbaum, R. L. Exclusion of the CAD locus from 2p2101-p23.3 using 2p interstitial deletions from patients with holoprosencephaly. (Abstract) Am. J. Hum. Genet. 45 (suppl.): A84, 1989.
Odent, S., Le Marec, B., Munnich, A., Le Merrer, M., Bonaiti-Pellie, C. Segregation analysis in nonsyndromic holoprosencephaly. Am. J. Med. Genet. 77: 139-143, 1998. [PubMed: 9605287]
Paulussen, A. D. C., Schrander-Stumpel, C. T., Tserpelis, D. C. J., Spee, M. K. M., Stegmann, A. P. A., Mancini, G. M., Brooks, A. S., Collee, M., Maat-Kievit, A., Simon, M. E. H., van Bever, Y., Stolte-Dijkstra, I., and 15 others. The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes. Europ. J. Hum. Genet. 18: 999-1005, 2010. [PubMed: 20531442] [Full Text: https://doi.org/10.1038/ejhg.2010.70]
Pineda-Alvarez, D. E., Solomon, B. D., Roessler, E., Balog, J. Z., Hadley, D. W., Zein, W. M., Hadsall, C. K., Brooks, B. P., Muenke, M. A broad range of ophthalmologic anomalies is part of the holoprosencephaly spectrum. Am. J. Med. Genet. 155A: 2713-2720, 2011. [PubMed: 21976454] [Full Text: https://doi.org/10.1002/ajmg.a.34261]
Ribeiro, L. A., El-Jaick, K. B., Muenke, M., Richieri-Costa, A. SIX3 mutations with holoprosencephaly. Am. J. Med. Genet. 140A: 2577-2583, 2006. [PubMed: 17001667] [Full Text: https://doi.org/10.1002/ajmg.a.31377]
Schell, U., Wienberg, J., Kohler, A., Bray-Ward, P., Ward, D. E., Wilson, W. G., Allen, W. P., Lebel, R. R., Sawyer, J. R., Campbell, P. L., Aughton, D. J., Punnett, H. H., Lammer, E. J., Kao, F.-T., Ward, D. C., Muenke, M. Molecular characterization of breakpoints in patients with holoprosencephaly and definition of the HPE2 critical region 2p21. Hum. Molec. Genet. 5: 223-229, 1996. [PubMed: 8824878] [Full Text: https://doi.org/10.1093/hmg/5.2.223]
Solomon, B. D., Lacbawan, F., Jain, M., Domene, S., Roessler, E., Moore, C., Dobyns, W. B., Muenke, M. A novel SIX3 mutation segregates with holoprosencephaly in a large family. Am. J. Med. Genet. 149A: 919-925, 2009. [PubMed: 19353631] [Full Text: https://doi.org/10.1002/ajmg.a.32813]
Wallis, D. E., Roessler, E., Hehr, U., Nanni, L., Wiltshire, T., Richieri-Costa, A., Gillessen-Kaesbach, G., Zackai, E. H., Rommens, J., Muenke, M. Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly. Nature Genet. 22: 196-198, 1999. [PubMed: 10369266] [Full Text: https://doi.org/10.1038/9718]